Back to search

Japan· JP-2616707Q3020

ベンザルコニウム塩化物

A benzalkonium product containing ベンザルコニウム塩化物, registered in Japan by 大塚製薬工場, on the national reimbursement list. The same ATC class is registered in 3 of our 19 countries.

On Japan’s NHI price listATC R02AA16

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedベンザルコニウム塩化物ATCR02AA16REGISTER NO.JP-2616707Q3020PACKS LISTED0CHECKEDSeptember 25, 2026

Where it is registered

Benzalkonium is registered in 3 of 19 countries.

Countries holding a registration under ATC R02AA16 (benzalkonium), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 2 of them publish a price we can compare per daily dose

Benzalkonium · ATC R02AA16

3 / 19 countries

  • Czechiaprice
  • Japan
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

MHLW / PMDA (Japan)
Active substance
ベンザルコニウム塩化物
Manufacturer
大塚製薬工場
Country
Japan (JP)
ATC code
R02AA16
ATC class
Benzalkonium
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1 interaction on record for benzalkonium.

Graded by severity as the source publishes them — 1 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Benzalkonium · interactions on record

1 record

  • 1 moderate

Most severe, free to view

  • Hyaluronic acidM09AX01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Benzalkonium in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All benzalkonium products

Authorised across Europe · EMA

The same active substance is authorised in 8 EEA countries. Names it is sold under:

  • Czechia · Pharmatex
  • Estonia · Pharmatex
  • France · Pharmatex, Pharmatex 18,9 Mg Soft Vaginal Capsule
  • Hungary · Pharmatex
  • Lithuania · Pharmatex
  • Latvia · Pharmatex
  • Romania · Pharmatex
  • Slovakia · Pharmatex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b07a14fa-9319-425f-9108-30b6810d6d7a
GET /v1/drugs/b07a14fa-9319-425f-9108-30b6810d6d7a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "0.1%10mL",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "2616707Q3020",
  "category": "外用薬",
  "price_yen": 7,
  "generic_name": "ベンザルコニウム塩化物",
  "product_name_jp": null,
  "therapeutic_class": "2616",
  "transitional_expiry": null
}

See everything about benzalkonium.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.